Two-Year Outcomes of "Treat and Extend" Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

Arnold, Jennifer JCampain, AnnaBarthelmes, DanielSimpson, Judy MGuymer, RobynHunyor, Alex PMcAllister, Ian LEssex, RohanMorlet, NigelGillies, Mark C2015-12-100161-6420http://hdl.handle.net/1885/68315Purpose: To report 24-month outcomes of anti-vascular endothelial growth factor (VEGF) therapy for treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) using a treat and extend treatment regimen in routine clinical practice. DesiTwo-Year Outcomes of "Treat and Extend" Intravitreal Therapy for Neovascular Age-Related Macular Degeneration201510.1016/j.ophtha.2015.02.0092015-12-10